05/25/2011
https://www.congress.gov...
"I just think it is an area that is going to be ripe for a lot of work going forward."
"I've asked the FTC to investigate specifically whether Mylan Pharmaceuticals used incentives or exclusionary contracts with insurers, distributors, or pharmacies to deny an alternative product access ..."
"I think that certainly was an important victory for the agency that allows us to do important work in the pay-for-delay arena."
"And this could be part of the reason that our drug prices in America are double the average prices in Canada?"